Arugosins G and H: Prenylated polyketides from the marine-derived fungus Emericella nidulans var. acristata

Journal of Natural Products

Volumn 69, Issue 7, 2006, Pages 995-1000

  Kralj, Ana ^a   Kehraus, Stefan ^a   Krick, Anja ^a   Eguereva, Ekaterina ^a   Kelter, Gerhard ^b   Maurer, Martina ^b   Wortmann, Andreas ^b   Fiebig, Heinz Herbert ^b   König, Gabriele M ^a  

^a UNIVERSITY OF BONN   (Germany)

^b CHARLES RIVER LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARUGOSIN A; ARUGOSIN B; ARUGOSIN G; ARUGOSIN H; BENZOPHENONE DERIVATIVE; CYTOKINE; EMERICELLIN; FURANONE DERIVATIVE; INDOLE ALKALOID; MICROPERFURANONE; POLYKETIDE; SHAMIXANTHONE; STERIGMATOCYSTIN; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; EMERICELLA; EMINDOLE DA; ENDOPHYTE; FUNGUS ISOLATION; GREEN ALGA; HUMAN; HUMAN CELL; IC 50; IMMUNOSTIMULATION; MARINE ENVIRONMENT; MEDITERRANEAN SEA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRENYLATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SPECIES CULTIVATION; TUMOR CELL LINE;

ALGAE, GREEN; BACILLUS MEGATERIUM; CHLORELLA; CYTOKINES; DRUG SCREENING ASSAYS, ANTITUMOR; ESCHERICHIA COLI; FUNGI; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; INHIBITORY CONCENTRATION 50; MARINE BIOLOGY; MEDITERRANEAN SEA; PHENOLS; TUMOR CELLS, CULTURED; XANTHONES;

CHLOROPHYTA; EMERICELLA NIDULANS; FUNGI;

EID: 33747379476     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np050454f     Document Type: Article

References (32)

1. (a) König, G. M.; Wright A. D. Planta Med. 1996, 62, 193-211.
2. (b) Blunt, J. W.; Copp, B. R.; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Nat. Prod. Rep. 2005, 22, 15-61.
3. (c) Bugni T. S.; Ireland, C. M. Nat. Prod. Rep. 2004, 21, 143-163.
4. (d) König, G. M.; Kehraus, S.; Seibert, S. F.; Abdel-Lateff, A.; Müller, D. ChemBioChem 2006, 7, 229-238.
5. (a) Butler, M. S. Nat. Prod. Rep. 2005, 22, 162-195.
6. (b) McMorris, T. C. Bioorg. Med. Chem. 1999, 7, 881-886.
7. (c) Senzer, N.; Arsenau, J.; Richards, D.; Berman, B.; MacDonald, J. R.; Smith, S. Am. J. Clin. Oncol. 2005, 28, 36-42.
8. (d) Furness, M. S.; Robinson, T. P.; Ehlers, T.; Hubbard, R. B.; Arbiser, J. L.; Goldsmith, D. J.; Bowen, J. P. Curr. Pharm. Des. 2005, 11, 357-373.
9. (a) Ballantine, J. A.; Francis, D. J.; Hassall, C. H.; Wright, J. L. C. J. Chem. Soc. (C) 1970, 1175-1182.
10. (b) Kawahara, N.; Nozawa, K.; Nakajima, S.; Kawai, K. J. J. Chem. Soc., Perkin Trans. 1 1988, 907-911.
11. Hein, S. M.; Gloer, J. B.; Koster, B.; Malloch, D. J. Nat. Prod. 1998, 61, 1566-1567.
12. (a) Holker, J. S. E.; Lapper, R. D.; Simpson, T. J. J. Chem. Soc., Perkin Trans. 1 1974, 2135-2140.
13. (b) Chexal, K. K.; Holker, J. S. E.; Simpson, T. J. J. Chem. Soc., Perkin Trans. 1 1975, 549-554.
14. Ballantine, J. A.; Ferrito, V.; Hassall, C. H.; Jenkins, M. L. J. Chem. Soc., Perkin Trans. 1 1973, 1825-1830.
15. Nozawa, K.; Udagawa, S.; Nakajima; S.; Kawai, K. J. J. Chem. Soc., Chem. Commun. 1987, 1157-1159.
16. Fujimoto, H.; Satoh, Y.; Yamaguchi, K.; Yamazaki, M. Chem. Pharm. Bull. 1998, 46, 1506-1510.
17. (a) Pachler, K. G. R.; Steyn, P. S.; Vleggaar, R.; Wessels, P. L. J. Chem. Soc., Perkin Trans. 1 1976, 1182-1189.
18. (b) Cox, R. H.; Cole, R. J. J. Org. Chem. 1977, 42, 112-114.
19. (a) Hensens, O. D.; Zink, D.; Williamson, J. M.; Lotti, V. J.; Chang, R. S. L.; Goetz, M. A. J. Org. Chem. 1991, 56, 3399-3403.
20. (b) Fujimoto, H.; Nakamura, E.; Okuyama, E.; Ishibashi, M. Chem. Pharm. Bull. 2000, 48, 1436-1441.
21. (c) Itabashi, T.; Ogasawara, N.; Nozawa, K.; Kawai, K. Chem. Pharm. Bull. 1996, 44, 2213-2217.
22. (d) Itabashi, T.; Nozawa, K.; Miyaji, M.; Udagawa, S.; Nakajima, S.; Kawai, K. Chem. Pharm. Bull. 1992, 40, 3142-3144.
23. Chexal, K. K.; Fouweather, C.; Holker, J. S. E.; Simpson, T. J.; Young, K. J. Chem. Soc., Perkin Trans. 1 1974, 1584-1593.
24. Schulz, B.; Sucker, J.; Aust, H. J.; Krohn, K.; Ludewig, K.; Jones, P. G.; Döring, D. Mycol. Res. 1995, 99, 1007-1015.
25. (a) Wang, J.; Groopman, J. D. Mutat. Res. 1999, 424, 167-181.
26. (b) Bünger, J.; Westphal, G.; Mönnich, A.; Hinnendahl, B.; Hallier, E.; Müller, M. Toxicology 2004, 202, 199-211.
27. Morgan, E.; Varro, R.; Sepulveda, H.; Ember, J. A.; Wilson, J.; Lowe, L.; Chen, R.; Shivraj, L.; Agadir, A.; Campos, R.; Ernst, D.; Gaur, A. Clin. Immunol. 2004, 110, 252-266.
28. Höller, U.; König, G. M.; Wright, A. D. J. Nat. Prod. 1999, 62, 114-118.
29. Bringmann, G.; Lang, G.; Steffens, S.; Günther, E.; Schaumann, K. Phytochemistry 2003, 63, 437-443.
30. Dengler, W. A.; Schulte, J.; Berger, D. P.; Mertelsmann, R.; Fiebig, H. H. Anti-Cancer Drugs 1995, 6, 522-532.
31. Roth, T.; Burger, A. M.; Dengler, W. A.; Willmann, H.; Fiebig, H. H. In Contributions to Oncology; Fiebig, H. H., Burger, A. M., Eds.; Karger: Basel, 1999; Vol. 54, pp 145-156.
32. Fiebig, H. H.; Berger, D. P.; Dengler, W. A.; Wallbrecher, E.; Winterhalter, B. R. In Contributions to Oncology; Fiebig, H. H., Berger, D. P., Eds.; Karger: Basel, 1992; Vol. 42, pp 321-351.